Physician

Jorge Fortun, MD

According to 2025 Medicare claims, Jorge Fortun, MD (NPI: 1184736464) practices ophthalmology in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is UNIVERSITY OF MIAMI (NPI: 1649210741; TIN: 592579938) and primary practice location at 33418-3701.

Fortun's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,585 traditional Medicare patients, billed 81,586 HCPCS/CPT codes, and received $4,061,501 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 261 prescription claims across 122 beneficiaries totaling $10,018 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 148 records totaling $190,046. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,599,012 to $4,061,501. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.1M2015 Medicare payment: $2,599,012 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,621,612 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,459,591 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,482,596 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,594,705 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,883,922 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,219,771 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,326,997 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,815,059 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,061,501 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,23912,288$2,599,012
20161,29611,687$2,621,612
20171,25711,532$2,459,591
20181,29511,557$2,482,596
20191,30511,521$2,594,705
20201,26110,945$2,883,922
20211,28612,964$3,219,771
20221,20923,502$3,326,997
20231,39268,822$3,815,059
20241,58581,586$4,061,501

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$15K$31K2015 Drug cost: $16,023 (USD; Tot_Drug_Cst)2016 Drug cost: $13,544 (USD; Tot_Drug_Cst)2017 Drug cost: $17,664 (USD; Tot_Drug_Cst)2018 Drug cost: $30,850 (USD; Tot_Drug_Cst)2019 Drug cost: $29,420 (USD; Tot_Drug_Cst)2020 Drug cost: $26,378 (USD; Tot_Drug_Cst)2021 Drug cost: $23,193 (USD; Tot_Drug_Cst)2022 Drug cost: $26,328 (USD; Tot_Drug_Cst)2023 Drug cost: $15,330 (USD; Tot_Drug_Cst)2024 Drug cost: $10,018 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015100256$16,023
2016107267$13,544
2017121316$17,664
2018130430$30,850
2019123406$29,420
2020109300$26,378
2021114312$23,193
2022120333$26,328
2023129269$15,330
2024122261$10,018

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye4891,889$99
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4521,219$95
92014Established patient complete exam of visual system9061,294$88
92134Imaging of retina9302,541$30
92250Photography of the retina763865$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate673,064$3,178
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha551,226$690
Atropine SulfateAtropine Sulfate17641$593
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat241,716$398
LatanoprostLatanoprost311,275$361

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.146$184,114Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.2$5,932Alimera Sciences, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jorge Fortun, MD?

Tedicare shows public-source Medicare data for Jorge Fortun, MD (NPI 1184736464), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jorge Fortun, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jorge Fortun, MD?

Jorge Fortun, MD is linked to UNIVERSITY OF MIAMI (billing NPI 1649210741) in the available physician profile data.

Does Jorge Fortun, MD have Open Payments data?

Jorge Fortun, MD has 148 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.